Sign up
Log in
U.S. RESEARCH ROUNDUP- Alnylam Pharmaceuticals, Labcorp, Vertex Pharmaceuticals
Share
Listen to the news
U.S. RESEARCH ROUNDUP- Alnylam Pharmaceuticals, Labcorp, Vertex Pharmaceuticals

- Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alnylam Pharmaceuticals, Labcorp and Vertex Pharmaceuticals on Monday.


HIGHLIGHTS


* Alnylam Pharmaceuticals Inc ALNY.O: JP Morgan reinstates coverage with PT $150

* Eastman Chemical Co EMN.N: JP Morgan raises to overweight from

* Labcorp LH.N: Mizuho cuts target price to $230 from $257

* Newell Brands Inc NWL.O: JP Morgan cuts to from overweight

* Vertex Pharmaceuticals Inc VRTX.O: JP Morgan reinstates with overweight rating; PT $390

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.


* Abbvie Inc ABBV.N: Leerink Partners cuts target price to $152 from $155

* AES Corp AES.N: Susquehanna cuts target price to $24 from $30

* Alerus Financial Corp ALRS.O: Piper Sandler cuts target price to $19 from $20

* Alliancebernstein Holding LP AB.N: CFRA cuts target price by $3 to $33

* Alnylam Pharmaceuticals Inc ALNY.O: JP Morgan reinstates coverage with PT $150

* Arbor Realty Trust Inc ABR.N: JP Morgan cuts target price to $12.50 from $14

* Arbor Realty Trust Inc ABR.N: Wedbush cuts target price to $17 from $19

* Arcbest Corp ARCB.O: TD Cowen cuts target price to $141 from $145

* Bancorp Inc TBBK.O: Piper Sandler raises target price to $49 from $46

* Bank7 Corp BSVN.O: Piper Sandler cuts target price to $27 from $32

* Barnes Group Inc B.N: Oppenheimer cuts target price to $30 from $48

* Biomarin Pharmaceutical BMRN.O: JP Morgan reinstates with overweight rating, PT $111

* Biontech SE BNTX.O: JP Morgan reinstates coverage with rating, target $106

* BJ's Restaurants Inc BJRI.O: Piper Sandler cuts target price to $28 from $37

* Brunswick Corp BC.N: D.A. Davidson cuts target price to $77 from $94

* Carrier Global Corp CARR.N: JP Morgan cuts target price to $48 from $53

* Carter's Inc CRI.N: Wedbush cuts target price to $67 from $72

* Chart Industries Inc GTLS.N: BTIG cuts target price to $160 from $200

* Charter Communications Inc CHTR.O: Wells Fargo cuts target price to $460 from $550

* Chevron Corp CVX.N: Truist Securities cuts target price to $166 from $169

* Cincinnati Financial Corp CINF.O: Piper Sandler raises target price to $110 from $105

* City Holding Co CHCO.O: Piper Sandler raises target price to $97 from $96

* Colgate-Palmolive Co CL.N: JP Morgan raises target price to $83 from $81

* Comcast Corp CMCSA.O: Macquarie cuts target price to $43 from $46

* CTO Realty Growth Inc CTO.N: Jonestrading cuts target price to $21 from $25

* Dana Inc DAN.N: Wells Fargo cuts target price to $14 from $16

* Eastman Chemical Co EMN.N: JP Morgan raises to overweight from

* Exxon Mobil XOM.N: Truist Securities raises target price to $135 from $133

* First Financial Northwest Inc FFNW.O: D.A. Davidson cuts target price to $13 from $15

* First Internet Bancorp INBK.O: Piper Sandler cuts target price to $18 from $19

* First Interstate Bancsystem Inc FIBK.O: Piper Sandler cuts target price to $32 from $35

* First Merchants Corp FRME.O: Piper Sandler cuts target price to $36 from $38

* Harley-Davidson Inc HOG.N: D.A. Davidson cuts target price to $41 from $43

* Hartford Financial Services Group Inc HIG.N: Piper Sandler raises PT to $97 from $93

* Heritage Commerce Corp HTBK.O: Raymond James cuts target price to $9.50 from $10.50

* Honeywell International Inc HON.O: Daiwa Capital Markets cuts PT to $187 from $197

* Horizon Bancorp Inc HBNC.O: Piper Sandler cuts target price to $10 from $12

* Incyte Corp INCY.O: JP Morgan reinstates coverage with rating, target price $59

* Labcorp LH.N: Mizuho cuts target price to $230 from $257

* Lincoln Electric Holdings Inc LECO.O: Jefferies cuts target price to $215 from $230

* Lincoln Electric Holdings Inc LECO.O: Stifel cuts target price to $192 from $210

* Marine Products Corp MPX.N: D.A. Davidson cuts target price to $11 from $16

* Moderna Inc MRNA.O: JP Morgan reinstates coverage with rating, target price $93

* MVB Financial Corp MVBF.O: JP Morgan cuts target price to $28 from $30

* Newell Brands Inc NWL.O: JP Morgan cuts target price to $7 from $11

* Newell Brands Inc NWL.O: JP Morgan cuts to from overweight

* Olin Corp OLN.N: JP Morgan cuts target price to $48 from $75

* Olin Corp OLN.N: JP Morgan cuts to from overweight

* Pegasystems Inc PEGA.O: Barclays raises target price to $45 from $44

* Pilgrims Pride Corp PPC.O: CFRA raises target price by $3 to $29

* Principal Financial Group Inc PFG.O: Piper Sandler cuts target price to $74 from $80

* Republic Services Inc RSG.N: JP Morgan cuts target price to $160 from $164

* Saia Inc SAIA.O: TD Cowen cuts target price to $416 from $424

* Sandy Spring Bancorp Inc SASR.O: Piper Sandler cuts target price to $22 from $24

* Seacoast Banking Corporation of Florida SBCF.O: Piper Sandler cuts PT to $23 from $24

* Seacoast Banking Corporation of Florida SBCF.O: Raymond James cuts PT to $23 from $27

* Southstate Corp SSB.O: Raymond James cuts target price to $80 from $85

* Stellar Bancorp Inc STEL.N: Piper Sandler cuts target price to $27 from $28

* Stellar Bancorp Inc STEL.N: Raymond James cuts target price to $24 from $27

* Terex Corp TEX.N: JP Morgan cuts target price to $56 from $63

* Trico Bancshares TCBK.O: Piper Sandler cuts target price to $41 from $43

* Universal Insurance Holdings Inc UVE.N: Piper Sandler raises PT to $21 from $20

* Valero Energy Corp VLO.N: JP Morgan cuts target price to $171 from $176

* Valley National Bancorp VLY.O: JP Morgan cuts target price $10 from $11

* Valley National Bancorp VLY.O: JP Morgan cuts target price to from overweight

* Valley National Bancorp VLY.O: Piper Sandler cuts target price to $8 from $9

* Vertex Pharmaceuticals Inc VRTX.O: JP Morgan reinstates with overweight rating; PT $390

* Wesbanco Inc WSBC.O: Piper Sandler cuts target price to $26 from $27


(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.